Table 5_2_3.1
Adult patients with HIV and CD4 count <50 who received Mycobacterium avium complex (MAC) prophylaxis,a United States, 2003 and 2005
| Population group |
2005 |
2003 |
| Sample size |
Percent |
SE |
Sample size |
Percent |
SE |
| Total |
915 |
87.1 |
1.1 |
957 |
84.3 |
1.2 |
| Age |
18–44 |
624 |
86.1 |
1.4 |
672 |
85.6 |
1.4 |
| 45 and over |
291 |
89.3 |
1.8 |
285 |
81.4 |
2.3 |
| Race |
Non-Hispanic, White |
187 |
83.4 |
2.7 |
191 |
81.2 |
2.8 |
| Non-Hispanic, Black |
545 |
87.2 |
1.4 |
573 |
85.5 |
1.5 |
| Hispanic |
167 |
90.4 |
2.3 |
177 |
84.2 |
2.8 |
| Other |
* |
* |
* |
* |
* |
* |
| Gender |
Male |
667 |
87.7 |
1.3 |
724 |
84.3 |
1.4 |
| Female |
238 |
85.3 |
2.3 |
233 |
84.5 |
2.4 |
| Health insurance |
Private |
73 |
90.4 |
3.5 |
60 |
85.0 |
4.6 |
| Medicaid/dual eligible |
364 |
88.7 |
1.7 |
410 |
86.8 |
1.7 |
| Medicare |
151 |
81.5 |
3.2 |
127 |
82.7 |
3.4 |
| Other/uninsured |
159 |
88.1 |
2.6 |
151 |
86.8 |
2.8 |
a For HIV patients having at least two CD4 tests < 50 during the year.
* - Data do not meet the criteria for statistical reliability, data quality, or confidentiality.
Key: MAC: Mycobacterium avium complex; SE: standard error.
Source: Agency for Healthcare Research and Quality, Center for Delivery, Organization and Markets, HIV Research Network.